These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 11334764)

  • 1. Angiotensin, fibrinolysis, and vascular homeostasis.
    Vaughan DE
    Am J Cardiol; 2001 Apr; 87(8A):18C-24C. PubMed ID: 11334764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fibrinolytic balance, the renin-angiotensin system and atherosclerotic disease.
    Vaughan DE
    Eur Heart J; 1998 Jul; 19 Suppl G():G9-12. PubMed ID: 9717049
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiotensin and vascular fibrinolytic balance.
    Vaughan DE
    Am J Hypertens; 2002 Jan; 15(1 Pt 2):3S-8S. PubMed ID: 11824873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endothelial function, fibrinolysis, and angiotensin-converting enzyme inhibition.
    Vaughan DE
    Clin Cardiol; 1997 Nov; 20(11 Suppl 2):II-34-7. PubMed ID: 9422850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circadian activity of the endogenous fibrinolytic system in stable coronary artery disease: effects of beta-adrenoreceptor blockers and angiotensin-converting enzyme inhibitors.
    Sayer JW; Gutteridge C; Syndercombe-Court D; Wilkinson P; Timmis AD
    J Am Coll Cardiol; 1998 Dec; 32(7):1962-8. PubMed ID: 9857879
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of the renin-angiotensin system in vascular health: use of ACE inhibition to improve vascular function.
    Izzo JL
    Heart Dis; 2000; 2(5):380-3. PubMed ID: 11728286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Endothelium and endogenous fibrinolysis].
    Nordt TK; Bode C
    Z Kardiol; 2000 Mar; 89(3):219-26. PubMed ID: 10798278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of the fibrinolytic system in preventing myocardial infarction.
    Vaughan DE; Rouleau JL; Pfeffer MA
    Eur Heart J; 1995 Nov; 16 Suppl K():31-6. PubMed ID: 8869133
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vascular renin-angiotensin-system, endothelial function and atherosclerosis?
    Holtz J; Goetz RM
    Basic Res Cardiol; 1994; 89 Suppl 1():71-86. PubMed ID: 7945178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Anti-atherosclerotic action of ACE inhibitors. I. Inactivation of the renin-angiotensin system].
    Stajszczyk M; Gmiński J
    Postepy Hig Med Dosw; 1996; 50(2):157-71. PubMed ID: 8848424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacology of ACE inhibitors versus AT1 blockers.
    Vaughan D
    Can J Cardiol; 2000 Aug; 16 Suppl E():36E-40E. PubMed ID: 10906625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The renin-angiotensin-aldosterone system and fibrinolysis.
    Felmeden DC; Lip GY
    J Renin Angiotensin Aldosterone Syst; 2000 Sep; 1(3):240-4. PubMed ID: 11881031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prothrombotic effects of angiotensin.
    Brown NJ; Vaughan DE
    Adv Intern Med; 2000; 45():419-29. PubMed ID: 10635057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renin angiotensin system and ASCVD.
    Farmer JA
    Curr Opin Cardiol; 2000 May; 15(3):141-50. PubMed ID: 10952419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of a long-term pharmacological interruption of the renin-angiotensin system on the fibrinolytic system in essential hypertension.
    Sakata K; Pawlak R; Urano T; Takada A
    Pathophysiol Haemost Thromb; 2002; 32(2):67-75. PubMed ID: 12214151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antihypertensive drugs and fibrinolytic function.
    Fogari R; Zoppi A
    Am J Hypertens; 2006 Dec; 19(12):1293-9. PubMed ID: 17161777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of chronic angiotensin II type I receptor antagonism and angiotensin converting enzyme inhibition on plasma fibrinolytic variables in patients with heart failure.
    Davie AP; Rumley A; Lowe GD; McMurray JJ
    Thromb Haemost; 2001 Dec; 86(6):1585-6. PubMed ID: 11776334
    [No Abstract]   [Full Text] [Related]  

  • 18. Endogenous NO regulates plasminogen activator inhibitor-1 during angiotensin-converting enzyme inhibition.
    Brown NJ; Muldowney JA; Vaughan DE
    Hypertension; 2006 Mar; 47(3):441-8. PubMed ID: 16432054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of lisinopril, irbesartan, and amlodipine on the thrombogenic variables in the early and late stages of the treatment in hypertensive patients.
    Tiryaki O; Usalan C; Buyukhatipoglu H; Sayiner ZA; Kilisli H
    Clin Exp Hypertens; 2012; 34(2):145-52. PubMed ID: 21967026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of endothelium in antithrombotic effect of the renin-angiotensin system blockade.
    Buczko W; Matys T; Kucharewicz I; Chabielska E
    J Physiol Pharmacol; 1999 Dec; 50(4):499-507. PubMed ID: 10639001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.